Charles Bernhardt

Charles "Chip" Bernhardt serves as Controller at Avstera Therapeutics Corp. since January 2022, overseeing the implementation of the CEO and Board's goals, cash flow management, and comprehensive accounting functions. Concurrently, since 2020, Bernhardt has held the position of Controller at Advaite Inc., managing various accounting activities and producing financial reports while ensuring compliance with tax and regulatory requirements. Previous roles include Interim Chief Financial Officer & Controller at SAK Fiscal Services, and Chief Financial Officer at Active Day, where strategic partnerships and financial analysis were crucial. Additional experience includes leadership positions at Echo Therapeutics, AIM ImmunoTech, Thomson Reuters, and TelAmerica Media. Bernhardt holds a Bachelor’s Degree in Accounting from Villanova University and an MBA in Business Administration from West Chester University of Pennsylvania.